Correction: Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD) (Molecular Psychiatry, (2020), 25, 7, (1592-1603), 10.1038/s41380-018-0256-5)

Maurizio Fava; Marlene P. Freeman; Martina Flynn; Heidi Judge; Bettina B. Hoeppner; Cristina Cusin; Dawn F. Ionescu; Sanjay J. Mathew; Lee C. Chang; Dan V. Iosifescu; James Murrough; Charles Debattista; Alan F. Schatzberg; Madhukar H. Trivedi; Manish K. Jha; Gerard Sanacora; Samuel T. Wilkinson; George I. Papakostas

doi:10.1038/s41380-018-0311-2

Correction: Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD) (Molecular Psychiatry, (2020), 25, 7, (1592-1603), 10.1038/s41380-018-0256-5)

Maurizio Fava, Marlene P. Freeman, Martina Flynn, Heidi Judge, Bettina B. Hoeppner, Cristina Cusin, Dawn F. Ionescu, Sanjay J. Mathew, Lee C. Chang, Dan V. Iosifescu, James Murrough, Charles Debattista, Alan F. Schatzberg, Madhukar H. Trivedi, Manish K. Jha, Gerard Sanacora, Samuel T. Wilkinson, George I. Papakostas

Research output: Contribution to journal › Comment/debate

11 Scopus citations

Abstract

Supplementary Figure 1 and Supplementary Tables 1–4 have been re-uploaded so as to reflect the versions supplied during proofs stage. The publisher apologizes for the error in versioning. The HTML version of the paper has been updated.

Original language	English
Pages (from-to)	1604
Number of pages	1
Journal	Molecular Psychiatry
Volume	25
Issue number	7
DOIs	https://doi.org/10.1038/s41380-018-0311-2
State	Published - 1 Jul 2020

Access to Document

10.1038/s41380-018-0311-2

Fingerprint

Dive into the research topics of 'Correction: Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD) (Molecular Psychiatry, (2020), 25, 7, (1592-1603), 10.1038/s41380-018-0256-5)'. Together they form a unique fingerprint.

Cite this

Fava, M., Freeman, M. P., Flynn, M., Judge, H., Hoeppner, B. B., Cusin, C., Ionescu, D. F., Mathew, S. J., Chang, L. C., Iosifescu, D. V., Murrough, J., Debattista, C., Schatzberg, A. F., Trivedi, M. H., Jha, M. K., Sanacora, G., Wilkinson, S. T., & Papakostas, G. I. (2020). Correction: Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD) (Molecular Psychiatry, (2020), 25, 7, (1592-1603), 10.1038/s41380-018-0256-5). Molecular Psychiatry, 25(7), 1604. https://doi.org/10.1038/s41380-018-0311-2

@article{de97b2d7ecaa4f32acfdb4f500e87a40,

title = "Correction: Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD) (Molecular Psychiatry, (2020), 25, 7, (1592-1603), 10.1038/s41380-018-0256-5)",

abstract = "Supplementary Figure 1 and Supplementary Tables 1–4 have been re-uploaded so as to reflect the versions supplied during proofs stage. The publisher apologizes for the error in versioning. The HTML version of the paper has been updated.",

author = "Maurizio Fava and Freeman, {Marlene P.} and Martina Flynn and Heidi Judge and Hoeppner, {Bettina B.} and Cristina Cusin and Ionescu, {Dawn F.} and Mathew, {Sanjay J.} and Chang, {Lee C.} and Iosifescu, {Dan V.} and James Murrough and Charles Debattista and Schatzberg, {Alan F.} and Trivedi, {Madhukar H.} and Jha, {Manish K.} and Gerard Sanacora and Wilkinson, {Samuel T.} and Papakostas, {George I.}",

note = "Publisher Copyright: {\textcopyright} 2019, Springer Nature Limited.",

year = "2020",

month = jul,

day = "1",

doi = "10.1038/s41380-018-0311-2",

language = "English",

volume = "25",

pages = "1604",

journal = "Molecular Psychiatry",

issn = "1359-4184",

publisher = "Nature Publishing Group",

number = "7",

}

Fava, M, Freeman, MP, Flynn, M, Judge, H, Hoeppner, BB, Cusin, C, Ionescu, DF, Mathew, SJ, Chang, LC, Iosifescu, DV, Murrough, J, Debattista, C, Schatzberg, AF, Trivedi, MH, Jha, MK, Sanacora, G, Wilkinson, ST & Papakostas, GI 2020, 'Correction: Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD) (Molecular Psychiatry, (2020), 25, 7, (1592-1603), 10.1038/s41380-018-0256-5)', Molecular Psychiatry, vol. 25, no. 7, pp. 1604. https://doi.org/10.1038/s41380-018-0311-2

Correction: Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD) (Molecular Psychiatry, (2020), 25, 7, (1592-1603), 10.1038/s41380-018-0256-5). / Fava, Maurizio; Freeman, Marlene P.; Flynn, Martina et al.
In: Molecular Psychiatry, Vol. 25, No. 7, 01.07.2020, p. 1604.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Correction

T2 - Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD) (Molecular Psychiatry, (2020), 25, 7, (1592-1603), 10.1038/s41380-018-0256-5)

AU - Fava, Maurizio

AU - Freeman, Marlene P.

AU - Flynn, Martina

AU - Judge, Heidi

AU - Hoeppner, Bettina B.

AU - Cusin, Cristina

AU - Ionescu, Dawn F.

AU - Mathew, Sanjay J.

AU - Chang, Lee C.

AU - Iosifescu, Dan V.

AU - Murrough, James

AU - Debattista, Charles

AU - Schatzberg, Alan F.

AU - Trivedi, Madhukar H.

AU - Jha, Manish K.

AU - Sanacora, Gerard

AU - Wilkinson, Samuel T.

AU - Papakostas, George I.

PY - 2020/7/1

Y1 - 2020/7/1

N2 - Supplementary Figure 1 and Supplementary Tables 1–4 have been re-uploaded so as to reflect the versions supplied during proofs stage. The publisher apologizes for the error in versioning. The HTML version of the paper has been updated.

AB - Supplementary Figure 1 and Supplementary Tables 1–4 have been re-uploaded so as to reflect the versions supplied during proofs stage. The publisher apologizes for the error in versioning. The HTML version of the paper has been updated.

UR - http://www.scopus.com/inward/record.url?scp=85086749520&partnerID=8YFLogxK

U2 - 10.1038/s41380-018-0311-2

DO - 10.1038/s41380-018-0311-2

M3 - Comment/debate

C2 - 30617276

AN - SCOPUS:85086749520

SN - 1359-4184

VL - 25

SP - 1604

JO - Molecular Psychiatry

JF - Molecular Psychiatry

IS - 7

ER -

Fava M, Freeman MP, Flynn M, Judge H, Hoeppner BB, Cusin C et al. Correction: Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD) (Molecular Psychiatry, (2020), 25, 7, (1592-1603), 10.1038/s41380-018-0256-5). Molecular Psychiatry. 2020 Jul 1;25(7):1604. doi: 10.1038/s41380-018-0311-2